MaxCyte, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MXCT research report →
About the company
MaxCyte, Inc. , a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering.
- CEO
- Maher Masoud
- IPO
- 2021
- Employees
- 91
- HQ
- Rockville, MD, US
Price Chart
- Market Cap
- $130.15M
- P/E
- -3.25
- P/S
- 4.03
- P/B
- 0.77
- EV/EBITDA
- -3.84
- Div Yield
- 0.00%
- Gross Margin
- 80.70%
- Op Margin
- -119.73%
- Net Margin
- -121.16%
- ROE
- -22.03%
- ROIC
- -20.82%
- Revenue
- $33.03M · -14.50%
- Net Income
- $-44,630,000 · -8.71%
- EPS
- $-0.42 · -7.69%
- Op Income
- $-45,285,000
- FCF YoY
- -23.64%
- 52W High
- $2.37
- 52W Low
- $0.64
- 50D MA
- $1.06
- 200D MA
- $1.20
- Beta
- 1.67
- Avg Volume
- 1.14M
Get TickerSpark's AI analysis on MXCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Johnston John Joseph | other | 30,421 |
| Jun 17, 26 | Johnston John Joseph | other | 49,579 |
| Jun 17, 26 | Hemrajani Rekha | other | 30,421 |
| Jun 17, 26 | Hemrajani Rekha | other | 49,579 |
| Jun 17, 26 | Erck Stanley C | other | 30,421 |
| Jun 17, 26 | Erck Stanley C | other | 49,579 |
| Jun 17, 26 | DOUGLAS RICHARD | other | 30,421 |
| Jun 17, 26 | DOUGLAS RICHARD | other | 49,579 |
| Jun 17, 26 | Collins Cynthia | other | 30,421 |
| Jun 17, 26 | Collins Cynthia | other | 49,579 |
Our MXCT coverage
Recent articles, reports, and earnings notes.
No research on MXCT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MXCT report →Similar companies
Peers in the same neighborhood.